Skip to content

Study · Case report or series · n = 1 · 2024

1 result

Food-induced small bowel obstruction observed in a patient with inappropriate use of semaglutide.

Itoh Y, Tani M, Takahashi R, Yamamoto K

Diabetology international9 Sept 2024Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesSafety outcome

    In a 30-year-old non-obese woman using semaglutide for weight loss, food-induced small bowel obstruction from kelp needed laparoscopic surgery; the authors could not prove a direct effect of semaglutide.

    In plain wordsIn one young woman using semaglutide to lose weight, a bowel blockage from kelp needed surgery. The report cannot prove semaglutide caused it.

    Outcome
    Not applicableFood-induced small bowel obstruction
    Study

    n = 1

    Outcome group
    Gastrointestinal adverse events · Gastrointestinal
    Studied dose
    1.0 mg weekly · subcutaneousAs given in this study (human).

    Source sentences

    Summary
    We herein report a case of food-induced small bowel obstruction (FIBO) while using a glucagon-like peptide 1 receptor agonist (GLP1-RA), trying to lose weight due to distorted body image.
    2 context sentences
    Summary · context
    Based on a finding of computed tomography at our emergency department, she was suspected of having a bowel obstruction and underwent laparoscopic surgery, which resulted in a diagnosis of small bowel obstruction by kelp.
    Summary · context
    The patient was a 30-year-old woman who was not obese (height 158 cm, weight 50 kg).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.